{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:24:33Z","timestamp":1784557473006,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14797-3","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:39:25Z","timestamp":1756363165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Salvage involved-field versus extended-field chemoradiotherapy for postoperative lymph node metastasis in esophageal squamous cell carcinoma: a retrospective clinical study"],"prefix":"10.1186","volume":"25","author":[{"given":"Wenqian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiguo","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"1","key":"14797_CR1","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","journal-title":"J Natl Cancer Cent"},{"issue":"9","key":"14797_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090\u20138.","journal-title":"Lancet Oncol"},{"issue":"5","key":"14797_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","volume":"32","author":"V Oppedijk","year":"2014","unstructured":"Oppedijk V, et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014;32(5):385\u201391.","journal-title":"J Clin Oncol"},{"issue":"5","key":"14797_CR4","doi-asserted-by":"publisher","first-page":"e97225","DOI":"10.1371\/journal.pone.0097225","volume":"9","author":"Q Liu","year":"2014","unstructured":"Liu Q, et al. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy. PLoS One. 2014;9(5):e97225.","journal-title":"PLoS One"},{"issue":"7","key":"14797_CR5","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/cncr.11228","volume":"97","author":"C Mariette","year":"2003","unstructured":"Mariette C, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97(7):1616\u201323.","journal-title":"Cancer"},{"issue":"22","key":"14797_CR6","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384.","journal-title":"N Engl J Med"},{"issue":"18","key":"14797_CR7","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","volume":"39","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39(18):1995\u20132004.","journal-title":"J Clin Oncol"},{"issue":"8","key":"14797_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","volume":"156","author":"H Yang","year":"2021","unstructured":"Yang H, et al. Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg. 2021;156(8):721\u20139.","journal-title":"JAMA Surg"},{"key":"14797_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1748-717X-9-28","volume":"9","author":"DY Ma","year":"2014","unstructured":"Ma DY, et al. Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study. Radiat Oncol. 2014;9:28.","journal-title":"Radiat Oncol"},{"key":"14797_CR10","unstructured":"Oncology GC..o.t.C.S.o.C., Chinese society of clinical oncology (CSCO). Guidelines for the diagnosis and treatment of esophageal cancer (2024 edition). Beijing: People\u2019s Medical Publishing House; 2024."},{"key":"14797_CR11","volume-title":"Target delineation in radiation therapy for esophageal cancer, in Target delineation in radiation therapy for esophageal cancer","author":"ZF Xiao","year":"2017","unstructured":"Xiao ZF, Li ZZYX, et al. Target delineation in radiation therapy for esophageal cancer, in Target delineation in radiation therapy for esophageal cancer. Beijing: People\u2019s Medical Publishing House; 2017."},{"issue":"2","key":"14797_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ijrobp.2009.02.078","volume":"76","author":"KL Zhao","year":"2010","unstructured":"Zhao KL, et al. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary? Int J Radiat Oncol Biol Phys. 2010;76(2):446\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"14797_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jjco\/hyw195","volume":"47","author":"K Jingu","year":"2017","unstructured":"Jingu K, et al. Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer. Jpn J Clin Oncol. 2017;47(3):200\u20135.","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"14797_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s10388-018-0622-z","volume":"15","author":"T Kawamoto","year":"2018","unstructured":"Kawamoto T, et al. Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer. Esophagus. 2018;15(4):256\u201362.","journal-title":"Esophagus"},{"issue":"4","key":"14797_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10388-022-00936-3","volume":"19","author":"R Ito","year":"2022","unstructured":"Ito R, et al. Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil\/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma. Esophagus. 2022;19(4):645\u201352.","journal-title":"Esophagus"},{"issue":"3","key":"14797_CR16","first-page":"2388","volume":"18","author":"Y Shi","year":"2019","unstructured":"Shi Y, et al. Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinoma. Oncol Lett. 2019;18(3):2388\u201393.","journal-title":"Oncol Lett"},{"issue":"17","key":"14797_CR17","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Radiation therapy oncology group, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA. 1999;281(17):1623\u20137.","journal-title":"JAMA"},{"issue":"1","key":"14797_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13014-019-1386-x","volume":"14","author":"HS Luo","year":"2019","unstructured":"Luo HS, Huang HC, Lin LX. Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis. Radiat Oncol. 2019;14(1):178.","journal-title":"Radiat Oncol"},{"key":"14797_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109463","volume":"180","author":"X Wang","year":"2023","unstructured":"Wang X, et al. High versus standard radiation dose of definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis of randomized clinical trials. Radiother Oncol. 2023;180: 109463.","journal-title":"Radiother Oncol"},{"issue":"9","key":"14797_CR20","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1158\/1078-0432.CCR-21-3843","volume":"28","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. A phase III multicenter randomized clinical trial of 60 Gy versus 50 Gy radiation dose in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma. Clin Cancer Res. 2022;28(9):1792\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"14797_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02099-y","volume":"17","author":"H Zhu","year":"2022","unstructured":"Zhu H, et al. Dose escalation based on (18)F-FDG PET\/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12). Radiat Oncol. 2022;17(1): 134.","journal-title":"Radiat Oncol"},{"issue":"1","key":"14797_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13014-019-1225-0","volume":"14","author":"S Gwynne","year":"2019","unstructured":"Gwynne S, et al. Driving developments in UK oesophageal radiotherapy through the SCOPE trials. Radiat Oncol. 2019;14(1):26.","journal-title":"Radiat Oncol"},{"issue":"1","key":"14797_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jtcvs.2021.10.033","volume":"164","author":"JK Yun","year":"2022","unstructured":"Yun JK, et al. Risk prediction of occult lymph node metastasis in patients with clinical T1 through T2 N0 esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2022;164(1):265\u2013e2755.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"14797_CR24","volume-title":"Chinese society of clinical oncology (CSCO) guidelines for the diagnosis and treatment of esophageal cancer (2019 edition)","author":"GC Oncology","year":"2019","unstructured":"Oncology GC. .o.t.C.S.o.C. Chinese society of clinical oncology (CSCO) guidelines for the diagnosis and treatment of esophageal cancer (2019 edition). Beijing: People\u2019s Medical Publishing House; 2019."},{"issue":"7","key":"14797_CR25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","volume":"17","author":"JA Ajani","year":"2019","unstructured":"Ajani JA, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(7):855\u201383.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"14797_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","volume":"21","author":"JA Ajani","year":"2023","unstructured":"Ajani JA, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(4):393\u2013422.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14797-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14797-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14797-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:43:18Z","timestamp":1757446998000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14797-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14797"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14797-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study involving human data was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Jiangsu Cancer Hospital (Approval No. [KY-2024-020]). The need for informed consent was waived by the ethics committee due to the retrospective design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1390"}}